New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Novavax, Inc.

NVAX

Healthcare Biotechnology

Novavax, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.1 billion, up 64.7% from fiscal 2024.

Revenue
−3.05%
EPS
n/m
Free cash flow
n/m
Total debt
+19.3%

Quarter to September 2026, against a year earlier

7.73 0.00 0.00%
Market cap
$1.3B
P/E
n/m
Fwd P/E FY26e
n/m
Dividend yield
—
F-score
5/9
ROIC
0.00%
Net debt / EBITDA
−1.0×
Payout ratio
—

What it owns vs. what it owes End of fiscal 2025, Dec 31, 2025

It holds $499.7M more in cash and short-term investments than it owes in debt. Debt has fallen from $316.3M to $246.3M since FY16. Liabilities are $127.8M more than assets: shareholders’ equity is negative. What is a balance sheet?

Dec 31, 2025 · total $1.2B

Owns

$198.2MLong-term assets
$232.3MOther short-term assets
$746.0MCash & short-term investments

Funded by

$1.1BOther liabilities
$246.3MDebt

Debt is 20.9% of the total; liabilities are $127.8M more than assets.

It went from net debt of 13% of assets to net cash of 42% of assets since FY16.

Total assetsNet debt (debt less cash)Net debt ÷ assets (right axis)
Assets and net debt, ten years
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Total assets$394M$302M$208M$173M$1.6B$2.6B$2.3B$1.8B$1.6B$1.2B
Net debt (debt less cash)$51M$132M$216M$239M−$443M−$1.2B−$1.1B−$355M−$710M−$500M
Net debt ÷ assets (right axis)12.8%43.7%104.0%138.1%−28.0%−46.7%−50.9%−19.7%−45.5%−42.5%
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Cash and Short Term Investments
265.79 185.54 102.98 81.77 804.93 1,526.61 1,347.19 578.93 933.74 745.96
Receivables
0.00 — — 7.50 262.01 454.99 82.38 297.24 108.29 106.45
Inventory
— — — — — 8.87 36.68 41.70 8.75 11.55
Other current assets
22.00 18.00 16.00 8.00 181.00 174.00 237.00 — — 87.51
Total current assets
287.83 203.31 119.28 97.25 1,248.20 2,155.12 1,703.39 1,143.89 1,128.94 978.28
Property, Plant, Equpment (Net)
40.18 35.99 28.43 11.45 179.95 225.74 294.25 305.77 138.41 44.80
Goodwill and Intangible Assets (Total)
60.90 61.44 58.51 56.74 141.10 131.48 126.33 127.45 107.48 113.46
Long-term assets (Other)
5.39 1.76 1.77 7.53 13.22 24.29 28.47 35.16 24.00 17.08
Total non-current assets
106.47 99.18 88.70 75.71 334.28 421.63 555.29 653.60 431.48 198.24
Total Assets
394.30 302.49 207.98 172.96 1,582.48 2,576.75 2,258.68 1,797.49 1,560.42 1,176.51
Notes Payable
— — — — — — 324.88 — — —
Accounts Payable
5.69 5.61 9.30 2.91 54.33 127.05 216.52 132.61 41.58 24.58
Accrued Expenses
29.59 34.69 24.63 19.95 137.39 673.73 591.16 394.67 211.17 107.17
Current Part of Capital Lease
— — — — 105.86 130.53 27.20 5.14 7.01 2.51
Current Revenue (Deferred)
30.08 25.63 10.01 1.68 273.23 1,422.94 370.14 241.31 675.07 140.05
Other current liabilities
1.06 7.75 1.60 1.26 8.86 36.06 930.06 861.41 219.60 185.65
Total current liabilities
66.41 73.68 45.54 25.80 579.67 2,390.32 2,459.94 1,635.14 1,154.42 459.95
Long Term Debt (Total)
316.34 317.76 319.19 320.61 362.12 323.46 197.70 223.94 223.41 246.30
Non-current Revenue (Deferred)
2.50 2.50 2.50 3.00 — 172.53 179.41 622.21 446.82 358.94
Non-current Liabilities (Other)
14.60 10.29 8.69 12.57 13.48 42.12 55.70 33.13 359.61 239.07
Total non-current liabilities
333.44 330.55 330.37 333.18 375.60 538.11 432.81 879.28 1,029.84 844.32
Total liabilities
399.85 404.23 375.91 358.97 955.27 2,928.43 2,892.76 2,514.42 2,184.26 1,304.27
Additional Paid In Capital
936.00 1,020.46 1,144.62 1,260.55 2,535.48 3,351.97 3,737.98 4,192.16 4,501.40 4,539.76
Common Stock (Net)
2.72 3.24 0.19 0.32 0.71 0.76 0.87 1.41 1.62 1.65
Retained Earnings
(930.00) (1,114.36) (1,299.11) (1,431.80) (1,874.20) (3,617.95) (4,275.89) (4,820.95) (5,008.45) (4,568.15)
Treasury Stock
2.45 2.45 2.45 2.58 41.81 85.10 90.66 92.27 95.85 103.02
Common Equity (Total)
(5.55) (101.73) (167.94) (186.02) 627.21 (351.67) (634.08) (716.93) (623.84) (127.75)
Shareholders Equity (Total)
(5.55) (101.73) (167.93) (186.02) 627.21 (351.67) (634.08) (716.93) (623.84) (127.75)
Shareholders Equity and Liabilities (Total)
394.30 302.49 207.98 172.96 1,582.48 2,576.75 2,258.68 1,797.49 1,560.42 1,176.51
Shares (Common)
13.56 16.16 19.22 32.35 70.95 75.84 86.04 139.51 160.42 162.58
Shareholders Equity (Tangible)
(66.44) (163.17) (226.44) (242.75) 486.11 (483.15) (760.41) (844.38) (731.32) (241.22)
Net Debt
50.55 132.23 216.21 238.84 (442.81) (1,203.15) (1,149.48) (354.99) (710.33) (499.66)
Total Debt
316.34 317.76 319.19 320.61 362.12 323.46 197.70 223.94 223.41 246.30

Fold the line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026